- ►diabetesjournals.org F Pistrosch, K Herbrig, B Kindel, J Passauer, S Fischer, … - Diabetes, 2005 - Am Diabetes Assoc Microalbuminuria, an early feature of diabetic nephropathy, indicates intrarenal endothelial
damage. In type 2 diabetes, microalbuminuria is strongly related to insulin resistance. We therefore
investigated whether rosiglitazone, an insulin-sensitizing drug that is known to improve ... Cited by 112 - Related articles - All 6 versions
PA Sarafidis, AN Lasaridis, PM Nilsson, AD … - American journal of …, 2005 - Elsevier The study involved 20 subjects with type 2 DM who were already on 15 mg glibenclamide daily
but were achieving poor glycemic control and who had either poorly controlled or newly diagnosed
hypertension. In these patients, rosiglitazone (4 mg daily) was added to the existing ... Cited by 38 - Related articles - All 4 versions
R Agarwal, C Saha, M Battiwala, N Vasavada, T … - Kidney international, 2005 - nature.com Diabetic nephropathy progresses relentlessly to end-stage renal disease (ESRD). Animal experiments
have found that peroxisome proliferator activated receptor- (PPAR- )–based therapy can have
a glucose independent effect on renal protection. We hypothesized that PPAR- –based ... Cited by 32 - Related articles - All 4 versions
G Bakris, G Viberti, WM Weston, M Heise, LE … - Journal of human …, 2003 - nature.com This study examines the effect of rosiglitazone on urinary albumin excretion (UAE) in patients
with type II diabetes. Urinary albumin: creatinine ratio (ACR) was measured in a 52-week,
open-label, cardiac safety study comparing rosiglitazone and glyburide. Patients were ... Cited by 241 - Related articles - BL Direct - All 3 versions
H Yamashita, Y Nagai, T Takamura, E Nohara, K … - Metabolism, 2002 - Elsevier Recent reports have shown that thiazolidinediones have preventive effects on urinary albumin
excretion in diabetes. However, the mechanism leading to these effects has not yet been
elucidated. We studied here the effects of thiazolidinediones on albuminuria and ... Cited by 58 - Related articles - BL Direct - All 6 versions
- ►asnjournals.org S Arima, K Kohagura, K Takeuchi, Y … - Journal of the American …, 2002 - Am Soc Nephrol ABSTRACT. Recent studies have demonstrated that thiazolidinediones, novel antidiabetic compounds
that improve the insulin sensitivity, lower BP and decrease urinary protein excretion.
However, neither the target vasculature nor the underlying mechanism for their actions is ... Cited by 32 - Related articles - BL Direct - All 4 versions
PA Sarafidis, GL Bakris - Kidney international, 2006 - nature.com The global epidemic of diabetes mellitus has led to a continuous increase in the prevalence
of diabetic nephropathy over the past years. Thus, diabetic nephropathy is currently the number
one cause of end-stage renal disease in the Western world. It represents a major public ... Cited by 72 - Related articles - BL Direct - All 4 versions
T Nakamura, C Ushiyama, S Osada, M Hara, N … - Metabolism, 2001 - Elsevier In various renal diseases, including diabetic nephropathy, detection of podocytes in the urine
indicates severe injury to podocytes in the glomeruli. Pioglitazone is a newly developed antidiabetic
agent that attenuates insulin resistance. The aim of the present study was to determine ... Cited by 116 - Related articles - BL Direct - All 6 versions
- ►physiology.org [PDF] R Agarwal - American Journal of Physiology- Renal Physiology, 2006 - Am Physiological Soc 35 articles, 19 of which you can access free at: This article cites http://ajprenal.physiology.org
/cgi/content/full/290/3/F600#BIBL ... 7 other HighWire hosted articles, the first 5 are: This article
has been cited by ... [PDF] [Full Text] [Abstract] , September 1, 2007; 293 (3): F670-F679. ... Cited by 40 - Related articles - BL Direct - All 7 versions
